Turnstone Biologics Corp. - Common Stock, par value $0.001 per share (TSBX)

31 filings reported holding TSBX - Turnstone Biologics Corp. - Common Stock, par value $0.001 per share as of Q4 2024.
Turnstone Biologics Corp. - Common Stock, par value $0.001 per share (TSBX) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 11.1M shares of 23.1M outstanding shares and own 47.95% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3.1M shares), FMR LLC (1.18M shares), Point72 Asset Management, L.P. (934K shares), PFM Health Sciences, LP (932K shares), TAKEDA PHARMACEUTICAL CO LTD (896K shares), BANK OF AMERICA CORP /DE/ (892K shares), CITADEL ADVISORS LLC (689K shares), VANGUARD GROUP INC (579K shares), 72 Investment Holdings, LLC (550K shares), and SECTORAL ASSET MANAGEMENT INC (518K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.